Isimpathy company information, Employees & Contact Information

iSIMPATHY is an EU funded project running until March 2023 across the three jurisdictions of Northern Ireland, Scotland and the border areas of the Republic of Ireland. The project ensures the best and most sustainable outcomes with medication use in patients taking multiple medicines. iSIMPATHY helps enable patients to lead healthy and active lives by supporting both them and clinicians to define and achieve realistic goals of drug treatment through medicine reviews. The project delivers the key principles of the WHO Third Global patient safety challenge, medication without harm. The project is delivering a systems approach that is scalable through cross-border shared learning. iSIMPATHY project objectives are: - To develop a whole-systems approach across health and care that ensures the optimal and sustainable use of medications for those with multiple morbidity to enable them to lead healthy and active lives - To develop guidance to support patients and clinicians in defining and achieving realistic goals of drug treatment, and systems change is necessary to aide implementation - To embed a whole-systems approach towards medicines reviews that is scalable in the three project jurisdictions - To share learning across the three jurisdictions to facilitate understanding and implementation of effective medicine reviews throughout the project’s lifespan iSIMPATHY builds on the SIMPATHY project and is working to deliver the recommendations of the SIMPATHY project: 1. Use a systems approach that has multidisciplinary clinical and policy leadership 2. Nurture a culture that encourages and prioritises the safety and quality of prescribing 3. Ensure that patients are integral to the decisions made about their medicines and are empowered and supported to do so 4. Use data to drive change and measure outcomes 5. Adopt an evidence based approach with a bias towards action 6. Utilise, develop and share tools to support implementation